Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Sarah Westlake"'
1
Akademický článek
Letters to the editor: Nicotinic acetylcholine receptor ligands as potential targets for managing neuropathic pain induced by diabetic peripheral neuropathy
Autor: Sarah Westlake, Matthew Jones, Krishna D. Sharma, Jennifer Yanhua Xie
Publikováno v: eNeurologicalSci, Vol 28, Iss , Pp 100416- (2022)
Diabetic peripheral neuropathy (DPN) is a medical condition that is progressively becoming more prevalent. The underlying cause of DPN is still unknown, although there have been several hypothesized mechanisms. There are current pharmaceutical treatm
Externí odkaz: https://doaj.org/article/a016258bf8124cf880cbc23290447d16
Zobrazit plný text záznamu
2
Immunosuppressants
Autor: Joanna Ledingham, Sarah Westlake
A variety of immunosuppressants and disease-modifying anti-rheumatic drugs (DMARDs) with beneficial effects on inflammatory rheumatic diseases have been identified over the last 50 years. Their use for these conditions is now well established and has
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f3f347e899bdb76223e2afef437df3b8
https://doi.org/10.1093/med/9780199642489.003.0080_update_001
Zobrazit plný text záznamu
3
Immunosuppressants
Autor: Joanna Ledingham, Sarah Westlake
A variety of immunosuppressants and disease-modifying anti-rheumatic drugs (DMARDs) with beneficial effects on inflammatory rheumatic diseases have been identified over the last 50 years. Their use for these conditions is now well established and has
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67677d2cfd9ce89058cd26aafa9dc61d
https://doi.org/10.1093/med/9780199642489.003.0080_update_002
Zobrazit plný text záznamu
4
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
Autor: Diana Finney, Rikki Abernethy, Tina Ding, Frank McKenna, Raashid Luqmani, Sarah Westlake, Kimme L. Hyrich, Ailsa Bosworth, Marwan Bukhari, Andrew Ostor, Mark Lunt, Chris Deighton, Patrick Kiely, Kate Gadsby, Jo Ledingham, Josh Dixey
Publikováno v: Rheumatology (Oxford, England). 49(11)
Inhibitors of TNF-a represent important treatment advances for a number of inflammatory conditions, including RA. TNF-a inhibitors offer a targeted strategy that contrasts with the non-specific immunosuppressive agents traditionally used to treat mos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f48c667dd10f68d62b3b2964790c89
https://pubmed.ncbi.nlm.nih.gov/20837498
Zobrazit plný text záznamu
8
A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
Autor: Robert Field, Lucy Edgson, Sarah Westlake
Publikováno v: Journal of Foot and Ankle Research, Vol 3, Iss Suppl 1, p P6 (2010)
Journal of Foot and Ankle Research
The BSR Biologics Register demonstrates increased risk of serious soft tissue infections in anti-TNFα managed patients. Mobility levels may increase with successful symptom management. However patients’ feet present with a combination of foot defo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed3015ee1851b9399640cf0c99651d4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje